{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:27Z","timestamp":1787761947226,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chorionic villus sampling (CVS) is one of the invasive diagnostic methods used to diagnose chromosomal, genetic, and metabolic diseases in the embryonic period. The use of this method is associated with maternal and fetal consequences, the most serious of which is abortion. Therefore, the present study was conducted to investigate the incidence of these consequences and the factors affecting the incidence of abortion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study was performed on 98 pregnant women with CVS indications. Maternal and fetal outcomes including abortion, vaginal bleeding, subchorionic hematoma, premature rupture of membrane (PROM), chorioamnionitis, preterm delivery, limb abnormality, fetal growth retardation, and preeclampsia were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results of the present study showed that the incidence of fetal outcomes including fetal growth failure, premature rupture of membranes, abortion, and limb abnormalities was 4.1%, 7.1%, 3.1%, and 1%, and the incidence of maternal outcomes including preterm delivery, subchorionic hematoma, preeclampsia, and hemorrhage was 14.3%, 3.1%, 6.1%, and 10.2%, respectively. In addition, a decrease in free BHCG and an increase in NT were significantly associated with the occurrence of abortion (OR: 0.11 and 4.25, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It should be noted that due to a long time between placental sampling and the occurrence of vaginal bleeding, premature rupture of membrane, and preterm delivery, it seems that placental sampling has no effect. In addition, only a decrease in free BHCG or an increase in NT significantly increased the chance of miscarriage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_229_22","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:40:03Z","timestamp":1684482003000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Fetal and Maternal Outcomes in Chorion Villus Sampling (CVS)"],"prefix":"10.4103","volume":"12","author":[{"given":"Minoo","family":"Movahedi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinaz","family":"Farahbod","sequence":"additional","affiliation":[{"name":"School of Medicine, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Zarean","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Child and Growth Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hajihashemi","sequence":"additional","affiliation":[{"name":"Department of Pelvic Floor, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedyeh","family":"Haghollahi","sequence":"additional","affiliation":[{"name":"Vali-E- Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Farahmand","sequence":"additional","affiliation":[{"name":"School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/JPR.S128300","article-title":"Maternal anxiety and its correlation with pain experience during chorion villus sampling and amniocentesis","volume":"10","author":"Klages","year":"2017","journal-title":"J Pain Res"},{"key":"R4-20240830","first-page":"25","article-title":"Pregnancy loss after amniocentesis and chorionic villus sampling: Cohort study","volume":"60","author":"Likar","year":"2020","journal-title":"Zdr Varst"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"101715","DOI":"10.1016\/j.jogoh.2020.101715","article-title":"Chorionic villus sampling: 10 years of experience in a University referral center","volume":"49","author":"Martins","year":"2020","journal-title":"J Gynecol Obstetr Hum Reprod"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.3346\/jkms.2021.36.e26","article-title":"Clinical practice guidelines for prenatal aneuploidy screening and diagnostic testing from Korean society of maternal-fetal medicine: (2) invasive diagnostic testing for fetal chromosomal abnormalities","volume":"36","author":"Lee","year":"2021","journal-title":"J Korean Med Sci"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/15513815.2019.1707919","article-title":"Fetal genetic diagnosis by chorionic villus sampling: Evaluation of the five-year experience from a single center","volume":"40","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"Fetal Pediatr Pathol"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/pd.2296","article-title":"The association between chorionic villus sampling and preeclampsia","volume":"29","author":"Grobman","year":"2009","journal-title":"Prenatal diagn"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/uog.22143","article-title":"Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: Systematic review and meta-analysis","volume":"56","author":"Di Mascio","year":"2020","journal-title":"Ultrasound Obstetr Gynecol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pd.5931","article-title":"Chromosomal mosaicism: Origins and clinical implications in preimplantation and prenatal diagnosis","volume":"41","author":"Levy","year":"2021","journal-title":"Prenat Diagn"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: Systematic review of literature and updated meta-analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/uog.20293","article-title":"Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis","volume":"54","author":"Beta","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jfma.2019.03.006","article-title":"Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study","volume":"118","author":"Hsu","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/uog.22041","article-title":"New approach for estimating risk of miscarriage after chorionic villus sampling","volume":"56","author":"Gil","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/pd.6021","article-title":"Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio?","volume":"41","author":"Mardy","year":"2021","journal-title":"Prenat Diagn"},{"key":"R16-20240830","first-page":"86","article-title":"Comparison of CVS and amniocentesis complications in patients referred to Ali Ibn Abitaleb Hospital of Zahedan","volume":"45","author":"Sanei Sistani","year":"2021","journal-title":"Res Med"},{"key":"R17-20240830","first-page":"241","article-title":"Comparison of complications of chorionic villus sampling and amniocentesis","volume":"5","author":"Shahbazian","year":"2012","journal-title":"Int J Fertil Steril"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/jpm-2015-0360","article-title":"Comparison of adverse perinatal outcomes after single-needle and double-needle CVS techniques","volume":"45","author":"Gezer","year":"2017","journal-title":"J Perinat Med"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1080\/14767058.2018.1454899","article-title":"Risk of preeclampsia in of women who underwent chorionic villus sampling","volume":"32","author":"Maruotti","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"892146","DOI":"10.3389\/fmed.2022.892146","article-title":"Intrauterine hematoma in the first trimester and pregnancy complications: A systematic review and meta-analysis","volume":"9","author":"Qin","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R21-20240830","first-page":"CD003252","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","volume":"9","author":"Alfirevic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ahg.12365","article-title":"Chorionic villus sampling experience of a reference perinatal medicine center","volume":"84","author":"Beksa\u00e7","year":"2020","journal-title":"Ann Hum Genet"},{"key":"R23-20240830","first-page":"400","article-title":"Pregnancy outcome in amniocentesis and chorionic villous sampling: Ten-year report","volume":"74","author":"Niromanesh","year":"2016","journal-title":"Tehran Univ Med J TUMS"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/AOG.0b013e3181875b92","article-title":"Evaluating the rate and risk factors for fetal loss after chorionic villus sampling","volume":"112","author":"Odibo","year":"2008","journal-title":"Obstetr Gynecol"},{"key":"R25-20240830","first-page":"345","article-title":"Procedure-related complications after genetic amniocentesis and chorionic villus sampling","volume":"34","author":"Kollmann","year":"2013","journal-title":"Ultraschall Ultraschall Med"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/uog.15986","article-title":"Total pregnancy loss after chorionic villus sampling and amniocentesis: A cohort study","volume":"49","author":"Bakker","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20240830","first-page":"1675","article-title":"Outcome of 1355 consecutive transabdominal chorionic villus samplings in 1351 patients","volume":"118","author":"Lau","year":"2005","journal-title":"Chin Med J"},{"key":"R28-20240830","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1080\/14767058.2018.1454899","article-title":"Risk of preeclampsia in of women who underwent chorionic villus sampling","volume":"32","author":"Maruotti","year":"2019","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_229_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:08:40Z","timestamp":1787760520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_229_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_229_22","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2022-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}